Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / REPL - Replimune gains as FDA to discuss path for rejected skin cancer drug

REPL - Replimune gains as FDA to discuss path for rejected skin cancer drug

Replimune Group Inc.

2025-09-02 15:00:47 ET

More on Replimune Group

For further details see:

Replimune gains as FDA to discuss path for rejected skin cancer drug

Stock Information
Company Name: Replimune Group Inc.
Stock Symbol: REPL
Market: NASDAQ
Website: replimune.com
Menu
REPL REPL Quote REPL Short REPL News REPL Articles REPL Message Board
Get REPL Alerts

News, Short Squeeze, Breakout and More Instantly...